Insider Transactions in Q3 2024 at Vor Biopharma Inc. (VOR)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 03
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
4,402
-7.97%
|
$0
$0.83 P/Share
|
|
Sep 03
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,657
-1.57%
|
$0
$0.83 P/Share
|
|
Sep 03
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,576
-3.14%
|
$0
$0.83 P/Share
|
|
Aug 06
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
206
-0.37%
|
$0
$0.87 P/Share
|
|
Aug 06
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.29%
|
$0
$0.87 P/Share
|
|
Aug 06
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-1.05%
|
$0
$0.87 P/Share
|
|
Aug 06
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
876
-0.49%
|
$0
$0.87 P/Share
|
|
Aug 01
2024
|
Amy Quinlan Vice President of Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
343
-0.61%
|
$0
$0.94 P/Share
|
|
Aug 01
2024
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
985
-0.55%
|
$0
$0.94 P/Share
|
|
Aug 01
2024
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,146
-1.19%
|
$0
$0.94 P/Share
|
|
Aug 01
2024
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,751
-0.34%
|
$0
$0.94 P/Share
|